Press Releases July 15, 2026 05:30 PM

Methanex Corporation

Methanex Corporation declares quarterly dividend amid stable market conditions

By Priya Menon
Share
Twitter Reddit Facebook LinkedIn
MEOH

Methanex Corporation, the world's largest methanol supplier, announced a quarterly dividend of US$0.185 per share payable on September 30, 2026, to shareholders of record as of September 16, 2026. The announcement signals financial stability but does not suggest significant operational changes.

Methanex Corporation
MEOH
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Declared a quarterly dividend of US$0.185 per share payable in Q3 2026.
  • Methanex is a leading global methanol supplier listed on both TSX and Nasdaq.
  • Financial position remains stable with continued shareholder returns.

VANCOUVER, British Columbia, July 15, 2026 (GLOBE NEWSWIRE) -- Methanex Corporation (the “Company” or “Methanex”) (TSX: MX) (Nasdaq: MEOH) announced today that its Board of Directors has declared a quarterly dividend of US$0.185 per share. The dividend will be payable on September 30, 2026, to holders of common shares of record on September 16, 2026.

About Methanex
Methanex is a Vancouver-based, publicly traded company and is the world's largest supplier of methanol globally. Methanex shares are listed for trading on the Toronto Stock Exchange in Canada under the trading symbol "MX" and on the Nasdaq Global Select Market in the United States under the trading symbol "MEOH". Methanex can be visited online at www.methanex.com.

Inquiries
Robert B. Winslow, CFA
Vice President, Investor Relations
Methanex Corporation
604-661-2600 or Toll Free: 1-800-661-8851
www.methanex.com


Risks

  • Dividend amount may not reflect future financial performance or market volatility in energy and chemical sectors.
  • Demand for methanol can be impacted by global economic conditions and energy market fluctuations.
  • Regulatory changes in environmental policies could affect methanol production and usage.

More from Press Releases

Cytokinetics Announces Additional Results from ACACIA-HCM and MAPLE-HCM Presented in Late Breaking Clinical Trial Session at the European Society of Cardiology (ESC) Congress 2026 Aug 29, 2026 Tenax Therapeutics Announces Presentation of Phase 3 LEVEL Results in Late-Breaking Scientific Sessions at ESC Congress 2026 Aug 29, 2026 20/20 BioLabs Reschedules Investor Webinar to 2:00 p.m. Eastern Time on September 2, 2026 to Discuss OneTest™ Revenue and Expanding Commercial Opportunity Aug 28, 2026 Trinity Biotech Provides Diagnostics Business, Transformation And Corporate Update Aug 28, 2026 AiRWA receives expected notification of deficiency from Nasdaq related to delayed filing of annual report on Form 10-K Aug 28, 2026